Moonwalk Biosciences raises $70m to test new muscle-sparing obesity drug in humans
Moonwalk Biosciences closed an oversubscribed $70 million Series B financing co-led by Alpha Wave and YK Bioventures, with participation from Eli Lilly and Company, Gaorong Ventures and existing investors ARCH Venture Partners, Khosla Ventures and Future Ventures, the company announced. The proceeds
<p>Moonwalk Biosciences closed an oversubscribed $70 million Series B financing co-led by Alpha Wave and YK Bioventures, with participation from Eli Lilly and Company, Gaorong Ventures and existing investors ARCH Venture Partners, Khosla Ventures and Future Ventures, the company announced. The proceeds</p>